🔎 Trials Near Me

Home › Rheumatoid Arthritis › Massachusetts

Rheumatoid Arthritis clinical trials in Massachusetts

8 studies for Rheumatoid Arthritis are looking for participants at sites in Massachusetts.

Cities in Massachusetts

RA-PRO PRAGMATIC TRIAL

  • Tufts University, Boston
  • University of Massachusetts Chan Medical School, Worcester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT04692493

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  • Massachusetts General Hospital, Boston
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 21, 2026 · NCT06570798

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  • Brigham And Womens Hospital, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT07115745

The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

  • Massachusetts General Hospital: Rheumatology, Boston
  • Brigham and Womens Hospital, Boston
  • Brigham and Women's Faulkner Hospital, Boston
RecruitingObservational study
Ages 35 to 79 · All sexes · Updated Jul 14, 2026 · NCT07315997

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

  • Tufts University, Boston
  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Jun 30, 2026 · NCT06201416

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

  • Research Site, New Bedford
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT07276581

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

  • Tufts University, Boston
  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
RecruitingObservational study
Ages 18 to 71 · All sexes · Updated Apr 16, 2026 · NCT07123038

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.